secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2024-08-16T23:59:59+00:00
Accession:  0001193125-24-202204
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed appoints Christopher DelOrefice to board of directors, effective August 15, 2024
--------------------------------------------------------------------------------

- DelOrefice is EVP and CFO of Becton Dickinson, brings 30+ years of audit, finance and strategic expertise.
- Board expanded to 11 members; DelOrefice will serve on audit committee.
- Appointment effective immediately; will stand for re-election at Nov 21, 2024 annual meeting.
- DelOrefice previously served as VP Investor Relations at Johnson & Johnson and CFO of North America Hospital Medical Devices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312524202204/0001193125-24-202204-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312524202204/d885393d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-202204

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer